Home · Solutions
LIRVEA by Sycai
AI solution for the detection and follow-up of solid hepatic lesions
Detects and monitors solid hepatic lesions from routine abdominal CT scans, supporting radiologists with automated longitudinal analysis from the first scan.
Proven performance in hepatic lesion detection
Works across scanner vendors and acquisition protocols.
Sensitivity of Detection
96.6 %
Standard of care surpassed
Specificity on Detection
88.3 %
High precision, low false positives
False Negative Rate
3.8 %
In detection
How LIRVEA™ works
Solution Features
Opportunistic detection of findings
Automates the identification of known or incidental lesions, with no manual trigger, flagging findings on any abdominal CT scan regardless of the reason it was ordered.
Characterization of lesions
Provides detailed lesion 2D & 3D measurements and precise anatomical location, structured and ready to include in the radiological report.
Automatic longitudinal analysis
Sycai Medical holds the only patent enabling automatic single-lesion tracking over time across multiple patient studies, ensuring standardized, consistent follow-up with no manual intervention.
Fully integrable in current workflow
LIRVEA™ works as a zero-click AI assistant, delivering findings automatically within the radiologist’s existing workflow. Seamlessly integrated into the PACS and RIS: no additional clicks, no setup changes required.
PANCRA™ is CE-Marked and ready to deploy
Clinically certified under EU MDR (Regulation 2017/745) and backed by ISO 13485 quality management. PANCRA™ is a market-ready medical device software, approved for use in adult patients.